Werewolf Therapeutics, Inc. (HOWL): Total Liabilities

Annual figures by period end, from SEC filings.

$44.59M
As of 2025-12-31
$35.99M
As of 2026-09-30
+5.6%
3-year compound annual growth
+44.1%
5-year compound annual growth
$63.46M2020-12-31: $7.18M2021-12-31: $26.46M2022-12-31: $37.91M2023-12-31: $63.46M2024-12-31: $53.54M2025-12-31: $44.59M$44.59M
2020-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$44.59M-16.7%2026-03-27, Balance as of period end
2024-12-31$53.54M-15.6%2026-03-27, Balance as of period end
2023-12-31$63.46M+67.4%2025-03-11, Balance as of period end
2022-12-31$37.91M+43.2%2024-03-07, Balance as of period end
2021-12-31$26.46M+268.6%2023-03-23, Balance as of period end
2020-12-31$7.18Mn/a2022-03-24, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Werewolf Therapeutics, Inc. (HOWL)2025-12-31$44.59M-16.7%
Spero Therapeutics, Inc. (SPRO)2025-12-31$9.90M-84.6%
Context Therapeutics Inc. (CNTX)2025-12-31$8.02M+180.4%
Corvus Pharmaceuticals, Inc. (CRVS)2025-12-31$9.91M-72.7%
Aldeyra Therapeutics, Inc. (ALDX)2025-12-31$27.81M-17.2%
Grace Therapeutics, Inc. (GRCE)2026-03-31$2.76M-48.8%
Incannex Healthcare Inc. (IXHL)2026-06-30$5.61M-20.6%
Inovio Pharmaceuticals, Inc. (INO)2025-12-31$50.21M+12.4%
Cumberland Pharmaceuticals Inc (CPIX)2025-12-31$52.28M-1.4%

Compare HOWL, SPRO, CNTX, CRVS side by side · Screen every company in Pharmaceutical Preparations ↗